Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells. Cancer Commun (Lond) 2024 Mar;44(3):448-452
Date
11/06/2023Pubmed ID
37930151Pubmed Central ID
PMC10958673DOI
10.1002/cac2.12500Scopus ID
2-s2.0-85176136734 (requires institutional sign-in at Scopus site) 4 CitationsAuthor List
Xiong D, Yin Z, Huang M, Wang Y, Hardy M, Kalyanaraman B, Wong ST, You MAuthors
Micael Joel Hardy PhD Visiting Assistant Professor in the Biophysics department at Medical College of WisconsinBalaraman Kalyanaraman PhD Professor in the Biophysics department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AtovaquoneEnergy Metabolism
Humans
Lung Neoplasms
Mitochondria
Tumor Microenvironment